Urogen Pharma Ltd (URGN)

Operating Expenses

$65.77M

Quarterly · Period ending: · USD

URGN logo

URGN Operating Expenses

Latest reported$65.77M
URGN Quarterly Operating Expenses ($1.18M → $65.77M)
High-resolution chart · PNG

URGN operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
65,773,000
67,083,000
53,663,000
51,590,000
62,113,000
54,838,000
49,752,000
40,296,000
45,458,000
42,793,000
35,853,000
31,985,000
34,078,000
36,972,000
36,111,000
32,164,000
33,473,000
33,996,000
34,500,000
33,547,000
34,428,000
32,702,000
34,568,000
32,276,000
32,124,000
38,561,000
39,839,000
23,453,000
23,771,000
22,433,000
24,017,000
20,317,000
18,480,000
13,691,000
10,198,000
7,820,000
5,951,000
3,539,000
3,601,000
6,110,000
3,395,000
3,598,000
7,029,000
2,034,000
1,182,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.